Startup nails $3.64M Series A for hemorrhage-control device

Medical device startup Innovative Trauma Care pulled in $3.64 million in a Series A funding round to ramp up commercialization plans for its ITClamp hemorrhage-control system. The company is developing trauma tools for use both by first responders and in military medicine on the front lines. A Health Canada approval is already in place, and a CE mark is likely by the end of 2012. FDA clearance is expected in 2013, the company said. Innovative Trauma Care is based in Edmonton, Canada, and San Antonio, TX. Release

Suggested Articles

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.

Ortho Clinical Diagnostics has launched a new chemistry system to complete its integrated Vitros XT line of laboratory solutions.

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.